Bixiye
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 3861 - 3870 ee natiijooyinka 4029
Bixiye
Rivfloza (nedosiran) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Rivfloza (nedosiran) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Peginterferon and Ribavirin - Medicaid
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Rapid to Intermediate Acting Insulin - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Ryplazim (plasminogen,human-tvmh) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Ryplazim (plasminogen,human-tvmh) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Kerendia - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025